Lindsay, 1993 - Google Patents
Pathogenesis of postmenopausal osteoporosisLindsay, 1993
- Document ID
- 8027047358358799987
- Author
- Lindsay R
- Publication year
- Publication venue
- Baillière's clinical rheumatology
External Links
Snippet
Osteoporosis is a disorder of ageing that shares with other disorders of ageing a multifactorial pathogenesis. The important factors for osteoporosis include the diet, life-style and intercurrent factors such as disease. However, it is clear that loss of ovarian function is …
- 230000008506 pathogenesis 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saggese et al. | Puberty and bone development | |
| Snow-Harter | Bone health and prevention of osteoporosis in active and athletic women | |
| Martin et al. | Menopause without symptoms: the endocrinology of menopause among rural Mayan Indians | |
| Wardlaw | Putting osteoporosis in perspective | |
| Lorentzon et al. | Leptin is a negative independent predictor of areal BMD and cortical bone size in young adult Swedish men | |
| Becker | Pathophysiology and clinical manifestations of osteoporosis | |
| Bennell et al. | Skeletal effects of menstrual disturbances in athletes | |
| Kun et al. | Improvement of bone health in childhood and adolescence | |
| Rosen et al. | The pathophysiology and treatment of postmenopausal osteoporosis: an evidence-based approach to estrogen replacement therapy | |
| Turner et al. | Effects of ethanol on gene expression in rat bone: Transient dose‐dependent changes in mRNA levels for matrix proteins, skeletal growth factors, and cytokines are followed by reductions in bone formation | |
| Lindsay | Pathogenesis of postmenopausal osteoporosis | |
| Birge | Osteoporosis and hip fracture | |
| Gordon Wardlaw Ph D | The effects of diet and life-style on bone mass in women | |
| Breslau | Calcium, estrogen, and progestin in the treatment of osteoporosis | |
| Lindsay | Prevention of postmenopausal osteoporosis | |
| Matsuo et al. | Relationship of upper body fat distribution to higher regional lean mass and bone mineral density | |
| Notelovitz | Post-menopausal osteoporosis: a practical approach to its prevention | |
| Lindsay et al. | Estrogens and osteoporosis | |
| Ross et al. | Overview of calcium | |
| Devogelaer et al. | Osteogenesis imperfecta: current treatment options and future prospects | |
| EP0804202A1 (en) | Estrogens and parathyroid hormone for treating osteoporosis | |
| Marcus | Understanding and preventing osteoporosis | |
| Wahlqvist et al. | Nutrition for bone and dental health | |
| Anderson | Development and maintenance of bone mass through the life cycle | |
| Gooren | Osteoporosis and sex steroids |